PharmiWeb.com - Global Pharma News & Resources

Avidity Biosciences

Research & Development

Avidity Biosciences is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases.